George L. McLendon, PhD


Dr. George McLendon has over four decades experience in academics, research science, company building and executive leadership. Dr. McLendon is currently the CEO of ML Bio Solutions, Inc. Previously, he served as the Vice President of Therapeutic Research and Development at Atrium Health. Prior to this role, he was Howard Hughes Provost and Professor of Chemistry at Rice University. Before joining Rice, Dr. McLendon was Dean of Arts and Sciences, Professor of Chemistry and Biochemistry at Duke University and faculty member of the Cancer Center at Duke University Medical School. Dr. McLendon was also the chair of the Department of Chemistry at Princeton University and Professor of Chemistry and Biochemistry at the University of Rochester. Dr. McLendon’s work has contributed to the establishment of several companies including Tetralogic, Steamtrax and Labcyte.  He is a founding co-director of TMCx, the largest accelerator for biomedical startups, and serves on advisory and governing boards for several early-stage life science companies.

Dr. McLendon earned a PhD degree in Chemistry from Texas A&M University.